OpenLB
Open Library of Bioscience
Advanced Search
Animals : an open access journal from MDPI
Jan 24, 2024;14 (3):

Treatment of Equine Tarsus Long Medial Collateral Ligament Desmitis with Allogenic Synovial Membrane Mesenchymal Stem/Stromal Cells Enhanced by Umbilical Cord Mesenchymal Stem/Stromal Cell-Derived Conditioned Medium: Proof of Concept.

Inês Leal Reis, Bruna Lopes, Patrícia Sousa, Ana Catarina Sousa, Mariana V Branquinho, Ana Rita Caseiro, Alexandra Rêma, Inês Briote, Carla M Mendonça, Jorge Miguel Santos, Luís M Atayde, Rui D Alvites, Ana Colette Maurício
Author Information
  1. Inês Leal Reis: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.
  2. Bruna Lopes: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ORCID
  3. Patrícia Sousa: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ORCID
  4. Ana Catarina Sousa: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ORCID
  5. Mariana V Branquinho: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ORCID
  6. Ana Rita Caseiro: Centro de Estudos de Ciência Animal (CECA), Instituto de Ciências, Tecnologias e Agroambiente da Universidade do Porto (ICETA), Rua D. Manuel II, Apartado 55142, 4051-401 Porto, Portugal. ORCID
  7. Alexandra Rêma: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ORCID
  8. Inês Briote: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.
  9. Carla M Mendonça: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.
  10. Jorge Miguel Santos: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.
  11. Luís M Atayde: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ORCID
  12. Rui D Alvites: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ORCID
  13. Ana Colette Maurício: Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), Universidade do Porto (UP), Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal. ORCID
PMID: 38338013 DOI: 10.3390/ani14030370

Abstract

Horses are high-performance athletes prone to sportive injuries such as tendonitis and desmitis. The formation of fibrous tissue in tendon repair remains a challenge to overcome. This impels regenerative medicine to develop innovative therapies that enhance regeneration, retrieving original tissue properties. Multipotent Mesenchymal Stem/Stromal Cells (MSCs) have been successfully used to develop therapeutic products, as they secrete a variety of bioactive molecules that play a pivotal role in tissue regeneration. These factors are released in culture media for producing a conditioned medium (CM). The aforementioned assumptions led to the formulation of equine synovial membrane MSCs (eSM-MSCs)-the cellular pool that naturally regenerates joint tissue-combined with a medium enriched in immunomodulatory factors (among other bioactive factors) produced by umbilical cord stroma-derived MSCs (eUC-MSCs) that naturally contribute to suppressing the immune rejection in the maternal-fetal barrier. A description of an equine sport horse diagnosed with acute tarsocrural desmitis and treated with this formulation is presented. Ultrasonographic ligament recovery occurred in a reduced time frame, reducing stoppage time and allowing for the horse's return to unrestricted competition after the completion of a physical rehabilitation program. This study focused on the description of the therapeutic formulation and potential in an equine desmitis treatment using the cells themselves and their secretomes.

Keywords

MSC-based therapies allogenic conditioned medium equine ligament mesenchymal stem/stromal cells orthobiologic secretome synovial membrane umbilical cord

References

  1. Vet Clin North Am Equine Pract. 2016 Apr;32(1):159-65 [PMID: 26898964]
  2. Methods Mol Biol. 2013;982:59-77 [PMID: 23456862]
  3. Cytotherapy. 2006;8(4):315-7 [PMID: 16923606]
  4. J Am Vet Med Assoc. 2023 Apr 11;261(7):995-1003 [PMID: 37040895]
  5. J Orthop Res. 2015 Jun;33(6):832-9 [PMID: 25641114]
  6. Vet Clin North Am Equine Pract. 2018 Aug;34(2):359-373 [PMID: 29803299]
  7. Animals (Basel). 2023 Apr 11;13(8): [PMID: 37106875]
  8. Muscles Ligaments Tendons J. 2012 Feb 15;1(3):68-76 [PMID: 23738251]
  9. J Appl Physiol (1985). 2011 Jun;110(6):1549-54 [PMID: 21350025]
  10. Can Vet J. 2011 May;52(5):519-23 [PMID: 22043073]
  11. Stem Cell Res Ther. 2014 Apr 16;5(2):53 [PMID: 24739658]
  12. Stem Cell Res Ther. 2021 Mar 18;12(1):192 [PMID: 33736695]
  13. Stem Cell Rev Rep. 2012 Jun;8(2):375-92 [PMID: 21892603]
  14. In Vivo. 2014 Nov-Dec;28(6):1119-23 [PMID: 25398809]
  15. Biochemistry (Mosc). 2019 Nov;84(11):1375-1389 [PMID: 31760924]
  16. Stem Cells Transl Med. 2017 Jun;6(6):1445-1451 [PMID: 28452204]
  17. Nat Rev Urol. 2019 Jun;16(6):363-375 [PMID: 30923338]
  18. Vet J. 2014 Oct;202(1):53-61 [PMID: 25151209]
  19. J Exp Med. 1996 Jun 1;183(6):2627-34 [PMID: 8676083]
  20. Stem Cell Res Ther. 2020 Aug 8;11(1):345 [PMID: 32771052]
  21. J Cell Biochem. 2012 May;113(5):1460-9 [PMID: 22213121]
  22. Injury. 2020 Dec;51(12):2855-2865 [PMID: 32201117]
  23. Inflamm Regen. 2016 Jul 5;36:8 [PMID: 29259681]
  24. Biotechnol Appl Biochem. 2018 Mar;65(2):104-118 [PMID: 28321921]
  25. Cells. 2019 May 16;8(5): [PMID: 31100966]
  26. Tissue Eng Part B Rev. 2009 Mar;15(1):75-86 [PMID: 19196118]
  27. Mediators Inflamm. 2017;2017:7517350 [PMID: 29362521]
  28. Stem Cell Res Ther. 2016 Sep 09;7(1):131 [PMID: 27612948]
  29. World J Stem Cells. 2014 Apr 26;6(2):195-202 [PMID: 24772246]
  30. Knee Surg Relat Res. 2020 Jan 1;32(1):5 [PMID: 32660594]
  31. FASEB J. 2020 Jun;34(6):8341-8356 [PMID: 32350938]
  32. Arthritis Rheum. 2001 Aug;44(8):1928-42 [PMID: 11508446]
  33. Biochem Biophys Rep. 2023 May 17;34:101486 [PMID: 37234487]
  34. Can Vet J. 2012 May;53(5):518-24 [PMID: 23115364]
  35. Knee Surg Sports Traumatol Arthrosc. 2013 Aug;21(8):1801-6 [PMID: 22983752]
  36. J Clin Med. 2023 Nov 16;12(22): [PMID: 38002750]
  37. Stem Cell Rev Rep. 2020 Apr;16(2):301-322 [PMID: 31797146]
  38. Biomed Res Int. 2014;2014:965849 [PMID: 25530971]
  39. Cells. 2020 Jun 11;9(6): [PMID: 32545382]
  40. J Biomech. 2006;39(1):61-9 [PMID: 16271588]
  41. Stem Cells Cloning. 2022 Apr 14;15:1-9 [PMID: 35444427]
  42. Commun Integr Biol. 2013 Nov 1;6(6):e26631 [PMID: 24567776]
  43. Methods. 2016 Apr 15;99:69-80 [PMID: 26384579]
  44. BMC Vet Res. 2022 Nov 7;18(1):391 [PMID: 36345002]
  45. Stem Cells Int. 2016;2016:7653489 [PMID: 26770213]
  46. J Transl Med. 2014 Oct 11;12:260 [PMID: 25304688]
  47. Vet Clin North Am Equine Pract. 2016 Apr;32(1):167-80 [PMID: 26898959]
  48. Stem Cells Transl Med. 2018 May;7(5):404-414 [PMID: 29573225]
  49. Med Sci Monit. 2018 Mar 16;24:1567-1573 [PMID: 29547593]
  50. Nanomaterials (Basel). 2019 Feb 14;9(2): [PMID: 30769853]

Grants

  1. MC-04/17; MC-18-2021/Prémios Santa Casa Neurociências
  2. UIDB/00211/2020/Fundação para a Ciência e Tecnologia
  3. 2022.04501.PTDC/Fundação para a Ciência e Tecnologia
  4. SFRH/BD/146689/2019/Fundação para a Ciência e Tecnologia
  5. 2021.05265.BD/Fundação para a Ciência e Tecnologia
  6. 2023.00246.BD/Fundação para a Ciência e Tecnologia
Journal Article

Word Cloud

Created with Highcharts 10.0.0equinedesmitistissueMesenchymalStem/StromalMSCsfactorsmediumformulationdeveloptherapiesregenerationCellstherapeuticbioactiveconditionedsynovialmembranenaturallyumbilicalcorddescriptionligamenttimecellsHorseshigh-performanceathletespronesportiveinjuriestendonitisformationfibroustendonrepairremainschallengeovercomeimpelsregenerativemedicineinnovativeenhanceretrievingoriginalpropertiesMultipotentsuccessfullyusedproductssecretevarietymoleculesplaypivotalrolereleasedculturemediaproducingCMaforementionedassumptionsledeSM-MSCs-thecellularpoolregeneratesjointtissue-combinedenrichedimmunomodulatoryamongproducedstroma-derivedeUC-MSCscontributesuppressingimmunerejectionmaternal-fetalbarriersporthorsediagnosedacutetarsocruraltreatedpresentedUltrasonographicrecoveryoccurredreducedframereducingstoppageallowinghorse'sreturnunrestrictedcompetitioncompletionphysicalrehabilitationprogramstudyfocusedpotentialtreatmentusingsecretomesTreatmentEquineTarsusLongMedialCollateralLigamentDesmitisAllogenicSynovialMembraneEnhancedUmbilicalCordCell-DerivedConditionedMedium:ProofConceptMSC-basedallogenicmesenchymalstem/stromalorthobiologicsecretome

Similar Articles

Cited By